Tag: Camille L. Bedrosian

Ultragenyx Pharmaceutical, Kyowa Kirin bag Crysvita FDA approval for TIO

pharmanewsdaily- June 19, 2020

Crysvita FDA approval for TIO : Ultragenyx Pharmaceutical and Kyowa Kirin have secured approval for their recombinant fully human monoclonal IgG1 antibody Crysvita (burosumab) from ... Read More

KIK-AS clinical trial : Angelman syndrome drug candidate GTX-102 to be evaluated by GeneTx Biotherapeutics

pharmanewsdaily- February 17, 2020

GeneTx Biotherapeutics is set to start the KIK-AS clinical trial for evaluating GTX-102 for the treatment of Angelman syndrome (AS), a rare, neurogenetic disorder resulting ... Read More